{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T10:04:12Z","timestamp":1769162652131,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>COVID 19 disease has become a global catastrophe over the past year that has claimed the lives of over two million people around the world. Despite the introduction of vaccines against the disease, there is still a long way to completely eradicate it. There are concerns about the complications following infection with SARS-CoV-2. This research aimed to evaluate the possible correlation between infection with SARS-CoV viruses and cancer in an in-silico study model. To do this, the relevent dataset was selected from GEO database. Identification of differentially expressed genes among defined groups including SARS-CoV, SARS-dORF6, SARS-BatSRBD, and H1N1 were screened where the |Log FC|\u2009\u2265\u20091and <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05 were considered statistically significant. Later, the pathway enrichment analysis and gene ontology (GO) were used by Enrichr and Shiny GO databases. Evaluation with STRING online was applied to predict the functional interactions of proteins, followed by Cytoscape analysis to identify the master genes. Finally, analysis with GEPIA2 server was carried out to reveal the possible correlation between candidate genes and cancer development. The results showed that the main molecular function of up- and down-regulated genes was \u201cdouble-stranded RNA binding\u201d and actin-binding, respectively. STRING and Cytoscape analysis presented four genes, <jats:italic>PTEN, CREB1, CASP3<\/jats:italic>, and <jats:italic>SMAD3<\/jats:italic> as the key genes involved in cancer development. According to TCGA database results, these four genes were up-regulated notably in pancreatic adenocarcinoma. Our findings suggest that pancreatic adenocarcinoma is the most probably malignancy happening after infection with SARS-CoV family.<\/jats:p>","DOI":"10.1038\/s41598-021-92068-4","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T10:03:10Z","timestamp":1624269790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The risk of pancreatic adenocarcinoma following SARS-CoV family infection"],"prefix":"10.1038","volume":"11","author":[{"given":"Amin","family":"Ebrahimi Sadrabadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Bereimipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arsalan","family":"Jalili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazaher","family":"Gholipurmalekabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6332-3067","authenticated-orcid":false,"given":"Behrouz","family":"Farhadihosseinabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8334-9376","authenticated-orcid":false,"given":"Alexander M.","family":"Seifalian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,21]]},"reference":[{"key":"92068_CR1","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1056\/NEJMp2008017","volume":"383","author":"B Pfefferbaum","year":"2020","unstructured":"Pfefferbaum, B. & North, C. S. Mental health and the Covid-19 pandemic. N. Engl. J. Med. 383, 510\u2013512 (2020).","journal-title":"N. Engl. J. Med."},{"key":"92068_CR2","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2020.12603","volume":"324","author":"A Carf\u00ec","year":"2020","unstructured":"Carf\u00ec, A., Bernabei, R. & Landi, F. J. J. Persistent symptoms in patients after acute COVID-19. JAMA 324, 603\u2013605 (2020).","journal-title":"JAMA"},{"key":"92068_CR3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ajog.2020.03.021","volume":"222","author":"P Dashraath","year":"2020","unstructured":"Dashraath, P. et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am. J. Obstet. Gynecol. 222, 521\u2013531 (2020).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"92068_CR4","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.2147\/RMHP.S261357","volume":"13","author":"A Jafari","year":"2020","unstructured":"Jafari, A. et al. Cancer care management during the COVID-19 pandemic. Risk Manag. Healthc. Policy 13, 1711 (2020).","journal-title":"Risk Manag. Healthc. Policy"},{"key":"92068_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajog.2018.12.011","volume":"221","author":"N Brusselaers","year":"2019","unstructured":"Brusselaers, N., Shrestha, S., Van De Wijgert, J. & Verstraelen, H. J. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: Systematic review and meta-analysis. Am. J. Obstet. Gynecol. 221, 9\u201318 (2019).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"92068_CR6","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.3390\/v6104047","volume":"6","author":"A Morales-S\u00e1nchez","year":"2014","unstructured":"Morales-S\u00e1nchez, A. & Fuentes-Panan\u00e1, E. M. J. V. Human viruses and cancer. Viruses 6, 4047\u20134079 (2014).","journal-title":"Viruses"},{"key":"92068_CR7","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1128\/JVI.07012-11","volume":"86","author":"K Bhardwaj","year":"2012","unstructured":"Bhardwaj, K., Liu, P., Leibowitz, J. L. & Kao, C. C. The coronavirus endoribonuclease Nsp15 interacts with retinoblastoma tumor suppressor protein. J. Virol. 86, 4294\u20134304 (2012).","journal-title":"J. Virol."},{"key":"92068_CR8","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","volume":"181","author":"V Monteil","year":"2020","unstructured":"Monteil, V. et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 181, 905\u2013913 (2020).","journal-title":"Cell"},{"key":"92068_CR9","doi-asserted-by":"publisher","first-page":"101084","DOI":"10.1016\/j.redox.2018.101084","volume":"25","author":"US Srinivas","year":"2019","unstructured":"Srinivas, U. S., Tan, B. W., Vellayappan, B. A. & Jeyasekharan, A. D. ROS and the DNA damage response in cancer. Redox Biol. 25, 101084 (2019).","journal-title":"Redox Biol."},{"key":"92068_CR10","doi-asserted-by":"crossref","unstructured":"Hayes, J. D., Dinkova-Kostova, A. T. & Tew, K. D. Oxidative stress in cancer. Cancer Cell (2020).","DOI":"10.1016\/j.ccell.2020.06.001"},{"key":"92068_CR11","doi-asserted-by":"publisher","first-page":"194416","DOI":"10.1016\/j.bbagrm.2019.194416","volume":"1863","author":"F Conte","year":"2020","unstructured":"Conte, F. et al. A paradigm shift in medicine: A comprehensive review of network-based approaches. Biochim. Biophys. Acta BBA Gene Regul. Mech. 1863, 194416 (2020).","journal-title":"Biochim. Biophys. Acta BBA Gene Regul. Mech."},{"key":"92068_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrg2918","volume":"12","author":"A-L Barab\u00e1si","year":"2011","unstructured":"Barab\u00e1si, A.-L., Gulbahce, N. & Loscalzo, J. Network medicine: A network-based approach to human disease. Nat. Rev. Genet. 12, 56\u201368 (2011).","journal-title":"Nat. Rev. Genet."},{"key":"92068_CR13","doi-asserted-by":"crossref","unstructured":"Tieri, P. et al. Network inference and reconstruction in bioinformatics. (2019).","DOI":"10.1016\/B978-0-12-809633-8.20290-2"},{"key":"92068_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41540-020-0133-0","volume":"6","author":"V Panebianco","year":"2020","unstructured":"Panebianco, V. et al. Prostate cancer screening research can benefit from network medicine: An emerging awareness. NPJ Syst. Biol. Appl. 6, 1\u20136 (2020).","journal-title":"NPJ Syst. Biol. Appl."},{"key":"92068_CR15","first-page":"406","volume":"64","author":"R Falcone","year":"2019","unstructured":"Falcone, R. et al. BRAF V600E-mutant cancers display a variety of networks by SWIM analysis: Prediction of vemurafenib clinical response. Endocr. Relat. Cancer 64, 406\u2013413 (2019).","journal-title":"Endocr. Relat. Cancer"},{"key":"92068_CR16","first-page":"1","volume":"8","author":"G Fiscon","year":"2018","unstructured":"Fiscon, G., Conte, F., Licursi, V., Nasi, S. & Paci, P. J. Computational identification of specific genes for glioblastoma stem-like cells identity. Sci. Rep. 8, 1\u201310 (2018).","journal-title":"Sci. Rep."},{"key":"92068_CR17","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.3390\/ijms21186690","volume":"21","author":"AM Grimaldi","year":"2020","unstructured":"Grimaldi, A. M. et al. The new paradigm of network medicine to analyze breast cancer phenotypes. Int. J. Mol. Sci. 21, 6690 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"92068_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41421-020-0153-3","volume":"6","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2. Cell Discov. 6, 1\u201318 (2020).","journal-title":"Cell Discov."},{"key":"92068_CR19","doi-asserted-by":"publisher","first-page":"e1008686","DOI":"10.1371\/journal.pcbi.1008686","volume":"17","author":"G Fiscon","year":"2021","unstructured":"Fiscon, G., Conte, F., Farina, L. & Paci, P. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19. PLOS Comput. Biol. 17, e1008686 (2021).","journal-title":"PLOS Comput. Biol."},{"key":"92068_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-021-04076-w","volume":"22","author":"G Fiscon","year":"2021","unstructured":"Fiscon, G. & Paci, P. SAveRUNNER: An R-based tool for drug repurposing. BMC Bioinform. 22, 1\u201310 (2021).","journal-title":"BMC Bioinform."},{"key":"92068_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"92068_CR22","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"MJPS Kanehisa","year":"2019","unstructured":"Kanehisa, M. J. P. S. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"92068_CR23","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Ishiguro-Watanabe, M. & Tanabe, M. KEGG: Integrating viruses and cellular organisms. Nucleic Acids Res. 49, D545\u2013D551 (2021).","journal-title":"Nucleic Acids Res."},{"key":"92068_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-00927-w","volume":"13","author":"H Qin","year":"2020","unstructured":"Qin, H. et al. RNA-binding proteins in tumor progression. J. Hematol. Oncol. 13, 1\u201323 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"92068_CR25","first-page":"148","volume":"10","author":"Y Sun","year":"2020","unstructured":"Sun, Y. et al. The aberrant expression of ADAR1 promotes resistance to BET inhibitors in pancreatic cancer by stabilizing c-Myc. Am. J. Cancer Res. 10, 148 (2020).","journal-title":"Am. J. Cancer Res."},{"key":"92068_CR26","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.3892\/ol.2016.4294","volume":"11","author":"XP Li","year":"2016","unstructured":"Li, X. P. et al. Overexpression of ribosomal L1 domain containing 1 is associated with an aggressive phenotype and a poor prognosis in patients with prostate cancer. Oncol. Lett. 11, 2839\u20132844 (2016).","journal-title":"Oncol. Lett."},{"key":"92068_CR27","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1530\/ERC-18-0442","volume":"26","author":"G Mantovani","year":"2019","unstructured":"Mantovani, G. et al. Cytoskeleton actin-binding proteins in clinical behavior of pituitary tumors. Endocr. Relat. Cancer 26, R95\u2013R108 (2019).","journal-title":"Endocr. Relat. Cancer"},{"key":"92068_CR28","doi-asserted-by":"crossref","unstructured":"Seetharaman, S. & Etienne-Manneville, S. Cytoskeletal crosstalk in cell migration. Trends Cell Biol. (2020).","DOI":"10.1016\/j.tcb.2020.06.004"},{"key":"92068_CR29","doi-asserted-by":"publisher","first-page":"R807","DOI":"10.1016\/j.cub.2020.05.041","volume":"30","author":"JDJCB Rotty","year":"2020","unstructured":"Rotty, J. D. J. C. B. Actin cytoskeleton: Profilin gives cells an edge. Curr. Biol. 30, R807\u2013R809 (2020).","journal-title":"Curr. Biol."},{"key":"92068_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.canlet.2004.03.020","volume":"212","author":"A Kaneda","year":"2004","unstructured":"Kaneda, A., Kaminishi, M., Sugimura, T. & Ushijima, T. Decreased expression of the seven ARP2\/3 complex genes in human gastric cancers. Cancer Lett. 212, 203\u2013210 (2004).","journal-title":"Cancer Lett."},{"key":"92068_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000365595","volume":"95","author":"G-H Liu","year":"2015","unstructured":"Liu, G.-H., Chen, J., Ji, Z.-G. & Zhou, L. Expression of neural wiskott-aldrich syndrome protein in clear cell renal cell carcinoma and its correlation with clinicopathological features. Urol. Int. 95, 79\u201385 (2015).","journal-title":"Urol. Int."},{"key":"92068_CR32","doi-asserted-by":"crossref","unstructured":"Steven, A. et al. What turns CREB on? And off? And why does it matter? Cell. Mol. Life Sci. (2020).","DOI":"10.1007\/s00018-020-03525-8"},{"key":"92068_CR33","doi-asserted-by":"publisher","first-page":"35454","DOI":"10.18632\/oncotarget.7721","volume":"7","author":"A Steven","year":"2016","unstructured":"Steven, A. & Seliger, B. J. O. Control of CREB expression in tumors: From molecular mechanisms and signal transduction pathways to therapeutic target. Oncotarget 7, 35454 (2016).","journal-title":"Oncotarget"},{"key":"92068_CR34","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.4049\/jimmunol.1001829","volume":"185","author":"AY Wen","year":"2010","unstructured":"Wen, A. Y., Sakamoto, K. M. & Miller, L. S. The role of the transcription factor CREB in immune function. J. Immunol. 185, 6413\u20136419 (2010).","journal-title":"J. Immunol."},{"key":"92068_CR35","doi-asserted-by":"publisher","first-page":"e12452","DOI":"10.1371\/journal.pone.0012452","volume":"5","author":"VO Melnikova","year":"2010","unstructured":"Melnikova, V. O. et al. CREB inhibits AP-2\u03b1 expression to regulate the malignant phenotype of melanoma. PLoS ONE 5, e12452 (2010).","journal-title":"PLoS ONE"},{"key":"92068_CR36","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1038\/oncsis.2014.21","volume":"3","author":"P Daniel","year":"2014","unstructured":"Daniel, P. et al. Selective CREB-dependent cyclin expression mediated by the PI3K and MAPK pathways supports glioma cell proliferation. Oncogenesis 3, e108\u2013e108 (2014).","journal-title":"Oncogenesis"},{"key":"92068_CR37","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.cell.2012.05.040","volume":"150","author":"MM Dix","year":"2012","unstructured":"Dix, M. M. et al. Functional interplay between caspase cleavage and phosphorylation sculpts the apoptotic proteome. Cell 150, 426\u2013440 (2012).","journal-title":"Cell"},{"key":"92068_CR38","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/ijc.31374","volume":"143","author":"M Zhou","year":"2018","unstructured":"Zhou, M. et al. Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells. Int. J. Cancer 143, 921\u2013930 (2018).","journal-title":"Int. J. Cancer"},{"key":"92068_CR39","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.molcel.2015.03.003","volume":"58","author":"X Liu","year":"2015","unstructured":"Liu, X. et al. Caspase-3 promotes genetic instability and carcinogenesis. Mol. Cell 58, 284\u2013296 (2015).","journal-title":"Mol. Cell"},{"key":"92068_CR40","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1158\/1078-0432.CCR-18-3001","volume":"25","author":"J Cheng","year":"2019","unstructured":"Cheng, J. et al. The caspase-3\/PKC\u03b4\/Akt\/VEGF-A signaling pathway mediates tumor repopulation during radiotherapy. Clin. Cancer Res. 25, 3732\u20133743 (2019).","journal-title":"Clin. Cancer Res."},{"key":"92068_CR41","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1021\/acschembio.9b00338","volume":"14","author":"MW Boudreau","year":"2019","unstructured":"Boudreau, M. W., Peh, J. & Hergenrother, P. Procaspase-3 overexpression in cancer: A paradoxical observation with therapeutic potential. ACS Chem. Biol. 14, 2335\u20132348 (2019).","journal-title":"ACS Chem. Biol."},{"key":"92068_CR42","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.4161\/cc.9.24.14158","volume":"9","author":"A Cooley","year":"2010","unstructured":"Cooley, A., Zelivianski, S. & Jeruss, J. S. Impact of cyclin E overexpression on Smad3 activity in breast cancer cell lines. Cell Cycle 9, 4900\u20134907 (2010).","journal-title":"Cell Cycle"},{"key":"92068_CR43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.lungcan.2016.04.017","volume":"97","author":"H Hu","year":"2016","unstructured":"Hu, H. et al. MiR-145 and miR-203 represses TGF-\u03b2-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells. Lung Cancer 97, 87\u201394 (2016).","journal-title":"Lung Cancer"},{"key":"92068_CR44","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2174\/1566524011313040001","volume":"13","author":"C Liu","year":"2013","unstructured":"Liu, C. et al. MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3. Curr. Mol. Med. 13, 467\u2013478 (2013).","journal-title":"Curr. Mol. Med."},{"key":"92068_CR45","doi-asserted-by":"publisher","first-page":"e61390","DOI":"10.7554\/eLife.61390","volume":"9","author":"NZ Cuervo","year":"2020","unstructured":"Cuervo, N. Z. & Grandvaux, N. ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities. Elife 9, e61390 (2020).","journal-title":"Elife"},{"key":"92068_CR46","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.cgh.2020.04.040","volume":"18","author":"F Liu","year":"2020","unstructured":"Liu, F. et al. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin. Gastroenterol. Hepatol. 18, 2128 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92068-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92068-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92068-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:06:15Z","timestamp":1675469175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92068-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,21]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["92068"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-92068-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,21]]},"assertion":[{"value":"3 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12948"}}